This Laviv market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.
Market growth during the historic period can be attributed to factors such as the increasing popularity and awareness of skin rejuvenation, rising demand for faster results and shorter treatment times, the growing preference for non-invasive aesthetic procedures, a higher demand for aesthetic fillers, and an expanding geriatric population.
In the forecast period, growth is expected to be driven by the rising adoption of skin rejuvenation products, increased demand for non-invasive aesthetic procedures, a growing preference for personalized solutions, the expansion of e-commerce channels, and the demand for innovative products. Key trends in the forecast period include advancements in regenerative medicine, the adoption of advanced technologies in production, greater consumer awareness and education, the proliferation of luxury and premium segments, and strategic collaborations and partnerships.
The rising demand for aesthetic treatments is expected to significantly drive the growth of the laviv market. Aesthetic treatments, which include non-surgical procedures aimed at enhancing or restoring an individual's appearance, are becoming increasingly popular. This demand is fueled by a greater awareness of personal appearance, advancements in non-invasive technologies, and growing emphasis on self-care and beauty standards. Laviv, a treatment used to improve skin appearance, works by stimulating collagen production to reduce wrinkles and enhance facial volume, offering a more youthful look. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of aesthetic procedures performed globally in 2023 reached 34.9 million, reflecting a 3.4% increase from the previous year. As more people opt for aesthetic treatments, the laviv market is expected to continue expanding.
The increasing focus on personalized medicine is contributing to the growth of the laviv market. Personalized medicine tailors treatments to individual patients based on factors such as genetic makeup, lifestyle, and environment. This approach has gained traction due to advancements in genomic medicine, better diagnostic tools, and a growing patient-centered focus in healthcare. Laviv supports personalized medicine by using the patient’s own fibroblast cells to create treatments that stimulate collagen production and enhance skin repair. For example, in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from six in 2022, reflecting the growing importance of personalized therapies. This shift towards customized treatments is expected to drive further demand for laviv.
The rising prevalence of skin conditions is factor fueling the growth of the laviv market. Increasing exposure to environmental pollutants, stress, and lifestyle changes, alongside an aging population, are contributing to a rise in skin conditions such as acne, wrinkles, and other skin irregularities. Laviv addresses these concerns by using autologous fibroblast therapy, which helps repair damaged skin, reduce wrinkles, and improve the appearance of acne scars. For instance, the American Cancer Society reported an increase in melanoma cases in the U.S. in 2023, with 58,120 men diagnosed compared to 57,180 in 2022. The growing incidence of skin conditions is expected to further drive the adoption of laviv treatments as individuals seek effective solutions to enhance their skin health and appearance.
The key company operating in the laviv market is Fibrocell Science Inc.
North America was the largest region in the laviv market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in laviv report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the laviv market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Laviv is a cell-based injectable therapy that utilizes a patient’s own fibroblast cells to rejuvenate and repair the skin. This personalized treatment involves harvesting fibroblasts from the patient, culturing them in a laboratory, and re-injecting them into targeted areas to stimulate collagen production. Laviv is primarily used for aesthetic purposes, offering a natural and biocompatible solution for skin rejuvenation.
The main formulations in the laviv market include injectable formulations (cell-based therapy) and lyophilized powder for reconstitution. The injectable formulation involves using a patient’s own fibroblast cells, which are extracted, cultured, and re-injected into the skin. Laviv is indicated for the treatment of facial wrinkles, acne scars, and other aesthetic applications. It caters to a wide range of patient demographics, including adults, geriatric individuals, and patients with specific skin conditions. The product is distributed through various channels, including direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies. Key end users include dermatology clinics, cosmetic surgery centers, hospitals, and medical spas.
The laviv market research report is one of a series of new reports that provides laviv market statistics, including laviv industry global market size, regional shares, competitors with a laviv market share, detailed laviv market segments, market trends, and opportunities, and any further data you may need to thrive in the laviv industry. This laviv market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laviv market consists of sales of wrinkle-reduction injectables, scar-treatment injectables, and general skin rejuvenation injectables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Market growth during the historic period can be attributed to factors such as the increasing popularity and awareness of skin rejuvenation, rising demand for faster results and shorter treatment times, the growing preference for non-invasive aesthetic procedures, a higher demand for aesthetic fillers, and an expanding geriatric population.
In the forecast period, growth is expected to be driven by the rising adoption of skin rejuvenation products, increased demand for non-invasive aesthetic procedures, a growing preference for personalized solutions, the expansion of e-commerce channels, and the demand for innovative products. Key trends in the forecast period include advancements in regenerative medicine, the adoption of advanced technologies in production, greater consumer awareness and education, the proliferation of luxury and premium segments, and strategic collaborations and partnerships.
The rising demand for aesthetic treatments is expected to significantly drive the growth of the laviv market. Aesthetic treatments, which include non-surgical procedures aimed at enhancing or restoring an individual's appearance, are becoming increasingly popular. This demand is fueled by a greater awareness of personal appearance, advancements in non-invasive technologies, and growing emphasis on self-care and beauty standards. Laviv, a treatment used to improve skin appearance, works by stimulating collagen production to reduce wrinkles and enhance facial volume, offering a more youthful look. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of aesthetic procedures performed globally in 2023 reached 34.9 million, reflecting a 3.4% increase from the previous year. As more people opt for aesthetic treatments, the laviv market is expected to continue expanding.
The increasing focus on personalized medicine is contributing to the growth of the laviv market. Personalized medicine tailors treatments to individual patients based on factors such as genetic makeup, lifestyle, and environment. This approach has gained traction due to advancements in genomic medicine, better diagnostic tools, and a growing patient-centered focus in healthcare. Laviv supports personalized medicine by using the patient’s own fibroblast cells to create treatments that stimulate collagen production and enhance skin repair. For example, in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from six in 2022, reflecting the growing importance of personalized therapies. This shift towards customized treatments is expected to drive further demand for laviv.
The rising prevalence of skin conditions is factor fueling the growth of the laviv market. Increasing exposure to environmental pollutants, stress, and lifestyle changes, alongside an aging population, are contributing to a rise in skin conditions such as acne, wrinkles, and other skin irregularities. Laviv addresses these concerns by using autologous fibroblast therapy, which helps repair damaged skin, reduce wrinkles, and improve the appearance of acne scars. For instance, the American Cancer Society reported an increase in melanoma cases in the U.S. in 2023, with 58,120 men diagnosed compared to 57,180 in 2022. The growing incidence of skin conditions is expected to further drive the adoption of laviv treatments as individuals seek effective solutions to enhance their skin health and appearance.
The key company operating in the laviv market is Fibrocell Science Inc.
North America was the largest region in the laviv market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in laviv report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the laviv market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Laviv is a cell-based injectable therapy that utilizes a patient’s own fibroblast cells to rejuvenate and repair the skin. This personalized treatment involves harvesting fibroblasts from the patient, culturing them in a laboratory, and re-injecting them into targeted areas to stimulate collagen production. Laviv is primarily used for aesthetic purposes, offering a natural and biocompatible solution for skin rejuvenation.
The main formulations in the laviv market include injectable formulations (cell-based therapy) and lyophilized powder for reconstitution. The injectable formulation involves using a patient’s own fibroblast cells, which are extracted, cultured, and re-injected into the skin. Laviv is indicated for the treatment of facial wrinkles, acne scars, and other aesthetic applications. It caters to a wide range of patient demographics, including adults, geriatric individuals, and patients with specific skin conditions. The product is distributed through various channels, including direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies. Key end users include dermatology clinics, cosmetic surgery centers, hospitals, and medical spas.
The laviv market research report is one of a series of new reports that provides laviv market statistics, including laviv industry global market size, regional shares, competitors with a laviv market share, detailed laviv market segments, market trends, and opportunities, and any further data you may need to thrive in the laviv industry. This laviv market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laviv market consists of sales of wrinkle-reduction injectables, scar-treatment injectables, and general skin rejuvenation injectables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Laviv Market Characteristics4. Laviv Market Trends and Strategies5. Laviv Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Laviv Pricing Analysis & Forecasts30. Global Laviv Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Laviv Market32. Recent Developments in the Laviv Market
3. Laviv Market Biologic Drug Characteristics
6. Global Laviv Growth Analysis and Strategic Analysis Framework
8. Laviv Market Segmentation
9. Global Laviv Epidemiology of Clinical Indications
10. Laviv Market Regional and Country Analysis
11. Asia-Pacific Laviv Market
12. China Laviv Market
13. India Laviv Market
14. Japan Laviv Market
15. Australia Laviv Market
16. South Korea Laviv Market
17. Western Europe Laviv Market
18. UK Laviv Market
19. Germany Laviv Market
20. France Laviv Market
21. Eastern Europe Laviv Market
22. North America Laviv Market
23. USA Laviv Market
24. Canada Laviv Market
25. South America Laviv Market
26. Middle East Laviv Market
27. Africa Laviv Market
28. Laviv Market Competitive Landscape and Company Profiles
29. Global Laviv Market Pipeline Analysis
33. Laviv Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Laviv Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on laviv market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for laviv? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The laviv market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Formulation: Injectable Formulation (Cell-Based Therapy); Lyophilized Powder For Reconstitution2) by Indication: Treatment of Facial Wrinkles; Treatment of Acne Scars; Other Aesthetic Applications
3) by Patient Demographics: Adult Patients; Geriatric Patients; Patients With Specific Skin Conditions
4) by Distribution Channel: Direct Sales; Wholesalers and Distributors; Retail Pharmacies; Online Pharmacies
5) by End User: Dermatology Clinics; Cosmetic Surgery Centers; Hospitals; Medical Spas
Key Companies Mentioned: Fibrocell Science Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Fibrocell Science Inc.
